生命科学资讯

Single-Cell Genome Sequencing Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com

The Analyst Verdict: Illumina In The Eyes Of 15 Experts - Benzinga

Clinical Ambitions: 10x Expands Beyond Research with Trio of Collaborations - GEN - Genetic Engineering and Biotechnology News

Illumina price driven lower by pivotal resistance - Forecast today - 26-01-2026 - Economies.com

Canaccord Genuity raises Illumina stock price target to $150 on solid results - Investing.com

Wealth Enhancement Advisory Services LLC Buys 9,997 Shares of Illumina, Inc. $ILMN - MarketBeat

iA Global Asset Management Inc. Purchases New Position in Illumina, Inc. $ILMN - MarketBeat

Is It Time To Reconsider Illumina (ILMN) After Mixed Multi Year Share Performance? - Yahoo Finance

Illumina (ILMN) Valuation Check After CMS Reimbursement Milestone In Precision Oncology - simplywall.st

Baillie Gifford & Co. Lowers Stake in Illumina, Inc. $ILMN - MarketBeat

Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology - 2 Minute Medicine

Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology - 2 Minute Medicine

Illumina, Inc. $ILMN Shares Sold by Teacher Retirement System of Texas - MarketBeat

Universal Beteiligungs und Servicegesellschaft mbH Purchases 40,166 Shares of Illumina, Inc. $ILMN - MarketBeat

$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players - Yahoo Finance Singapore

Why Illumina (ILMN) Is Up 5.9% After CMS Backs TruSight Oncology Comprehensive Reimbursement - simplywall.st

Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing

Dubai Health embraces genomics to advance care and research - Illumina

Illumina (NASDAQ:ILMN) Sets New 52-Week High - Here's What Happened - MarketBeat